Products/Services Used | Details | Operation |
---|---|---|
Codon Optimization> | . Synthetic fragments (obtained from GenScript, Piscataway, NJ, USA) containing the codon optimized PrM-sE sequences from DENV2 New Guinea C strain (GenBank accession number AF038403, aminoacids 117-675 of the viral polyprotein), DENV3 3H87 strain (GenBank accession number M93130, aminoacids 118-673) and ZIKV Mr766 strain (GenBank accession number AEN75266.1, aminoacids 122-694), and sE sequences form DENV1 Nauru Island strain (GenBank accession number U88535.1, aminoacids 281-675) and DENV4 Dominica strain (GenBank accession numbers AF326573.1, aminoacids 280-674) were obtained and fused to an amino-terminal immunoglobulin leader sequence (sec)63 and to a carboxy-terminal SV5 tag (GKPIPNPLLGLD)48 in pVAX vectors (Life Technologies) | Get A Quote |
Dengue and Zika are two of the most important human viral pathogens worldwide. In both cases, the envelope glycoprotein E is the main target of the antibody response. Recently, new complex quaternary epitopes were identified which are the consequence of the arrangement of the antiparallel E dimers on the viral surface. Such epitopes can be exploited to develop more efficient cross-neutralizing vaccines. Here we describe a successful covalent stabilization of E dimers from Dengue and Zika viruses in mammalian cells. Folding and dimerization of secretory E was found to be strongly dependent on temperature but independent of PrM co-expression. In addition, we found that, due to the close relationship between flavi... More